Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
Tags Companies Amgen Inc Pharmaceuticals
From CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
Tags Obesity Eli Lilly and Co Business
From CNBC.com News
Stocks making the biggest moves midday: Shutterstock, Newell Brands, Zillow and more
Tags 3M Co Novo Nordisk A/S Breaking News: Markets
From CNBC.com News
European regulator to review weight-loss drugs following reports of suicidal thoughts
Tags Business News Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Moderna strikes deal to develop mRNA drugs in China
Tags Moderna Inc Biotech and Pharmaceuticals Sanofi SA
From CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Tags Health care industry Pharmaceuticals Companies
From CNBC.com News
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
Tags Health & Science Business Eli Lilly and Co
From CNBC.com News
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
Tags Business Eli Lilly and Co Health & Science
From CNBC.com News
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
Tags Companies Pharmaceuticals Health care industry
From CNBC.com News
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
Tags Health & Science Size and weight discrimination Business
From CNBC.com News
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
Tickers LAW LAWS
Tags Business Health & Science Novo Nordisk A/S
From CNBC.com News
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
Tags Biotech and Pharmaceuticals Science Novo Nordisk A/S
From CNBC.com News
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Tags Health care industry Medication Pharmaceuticals
From CNBC.com News
Novo Nordisk cuts some U.S. supply of Wegovy obesity drug as demand soars
Tags Health Care Distributors Pharmaceuticals Medicine
From CNBC.com News
Obesity drug industry could be worth $200 billion within the decade, says Barclays, as market valuations grow
Tags Biotechnology Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds
Tags US: News Breaking News: Business Biotechnology
From CNBC.com News
Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices
Tags Congress Sanofi SA Policy
From CNBC.com News
Senate legislation would cap insulin at $35 per month for people with private insurance
Tags Sanofi SA Pandemics Congress
From CNBC.com News
Stocks making the biggest moves midday: Apple, Tesla, Netflix, Bed Bath & Beyond & more
Tags Bed Bath & Beyond Inc Alibaba Group Holding Ltd Novo Nordisk A/S
From CNBC.com News
Stocks making the biggest premarket moves: Delta, First Solar, Steve Madden & more
Tags Breaking News: Markets Markets Steven Madden Ltd
From CNBC.com News
Health misinformation is lowering U.S. life expectancy, FDA Commissioner Robert Califf says
Tags Eli Lilly and Co Emergent BioSolutions Inc Health & Science
From CNBC.com News
People taking obesity drugs Ozempic and Wegovy gain weight once they stop medication
Tags Breaking news Biotech and Pharmaceuticals US Top News and Analysis
From CNBC.com News
Sanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo Nordisk
Tags Breaking news Breaking News: Business Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly
Tags Eli Lilly and Co Health & Science Pharmaceuticals
From CNBC.com News
Biden proposal to cap all insulin prices at $35 a month has little chance of passing Congress
Tags Cigna Corp World News Health care industry
From CNBC.com News
Trending billionaire and celebrity GLP-1 weight loss drugs are about to enter more American homes
Tags Novo Nordisk A/S Weight management Obesity
From CNBC.com News
Cramer's lighting round: Stay away from Blackline
Tags Oramed Pharmaceuticals Inc S&P 500 Blackline Inc
From CNBC.com News
Cramer's lighting round: I like Danaher over Philips
Tags Mad Money U/S/ Markets Markets
From CNBC.com News
Marinus selling rare pediatric disease priority review voucher for $110M
Tags Health Care Marinus Pharmaceuticals Inc/ Steven Pfanstiel
From Business Journals
Stem cells may finally offer a cure for Type 1 diabetes
Tags Technology Health care industry Health & Science
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.